Skip to main content

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

Nasdaq confirms Company has regained compliance with Listing Rules 5550(b)(1) and 5620(a) SOLANA BEACH, Calif., April 07, 2026 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical‑stage pharmaceutical company focused on modulating lipid‑signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, today announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), the “Equity Rule,” and Listing Rule 5620(a), the “Annual Shareholders Meeting Rule.” Nasdaq further confirmed that, based on the Company’s Form 8-K filed January 30, 2026, the Company held its reconvened annual meeting on that date and, based on the Company’s Form 8-K filed March 30,...

Continue reading

Virtuix to Present at Exclusive Investor Forum at Mar-a-Lago Club in Palm Beach, Florida

Chief Executive Officer Jan Goetgeluk to Present at Private, Invitation-Only Dinner at Mar-a-Lago with Investors and Senior Government Officials AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) — Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced that Chief Executive Officer Jan Goetgeluk will present at a private, invitation-only roundtable taking place April 16, 2026, at the Mar-a-Lago Club in Palm Beach, Florida. Mr. Goetgeluk will meet with an exclusive group of institutional investors, high-net-worth individuals and senior government officials at Mar-a-Lago and also present at an investor lunch in West Palm Beach earlier in the day on April 16, 2026. Mr. Goetgeluk will discuss the Company’s growing traction for the Omni technology in the defense sector, with recent sales...

Continue reading

Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy

Texas agency’s initial purchase of BolaWrap devices, WrapTactics subscriptions, and in-person training supports broader expansion of tools, training, and policy-aligned NLR capabilities MIAMI, April 07, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) and public safety technology, today announced that the Galveston Police Department in Texas has adopted Wrap’s NLR solutions through the purchase of BolaWrap 150® devices and WrapTactics™ subscriptions, supported by in-person training. Wrap also expects additional expansion purchases to support broader deployment of NLR capabilities across various units within the department. Galveston Police Department serves a coastal community with an emphasis on personal security, community engagement,...

Continue reading

Værdipapirfonden Sparinvest – ophævelse suspension på alle afdelinger

Det skal herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves.  Ophævelsen gælder nedenstående afdelinger: Fund Name ISIN Order Book CodeINDEX Bæredygtige Virksomhedsobligationer HY KL DK0016028020 SPVBVOINDEX Emerging Market Bonds Lokalvaluta DK0060254043 SPVINOINDEX Emerging Market Bonds Lokalvaluta Akk. – KL A DK0060254126 SPVINOAKKKLAINDEX Globale Aktier KL DK0060747822 SPVIGAKLINDEX Globale Aktier Min. Risiko Akk. KL DK0060748127 SPVIGAMRAKLINDEX Bæredygtige Global KL DK0060747905 SPVIBGKLINDEX Bæredygtige USA KL DK0060748200 SPVBUSAKLINDEX Bæredygtige Europa KL DK0060748044 SPVBEUKLINDEX Lav Risiko KL DK0060748556 SPVILRKLINDEX Mellem Risiko KL DK0060748630 SPVIMRKLINDEX...

Continue reading

OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting

LONDON and NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that it will hold a key Scientific Advisory Board (SAB) meeting with leading ophthalmology experts during the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Washington, DC. The SAB meeting, scheduled to take place alongside the conference, will bring together prominent corneal and ocular surface disease specialists to review clinical data for the company’s lead candidate, urcosimod and provide strategic guidance on the upcoming clinical program. In conjunction with the SAB meeting, Dr. Pedram Hamrah, Professor of Ophthalmology,...

Continue reading

Highlander Silver Provides Update; Drilling Commences at Corani Silver Project

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) — Highlander Silver Corp. (TSX, NYSE American: HSLV) (“Highlander Silver” or the “Company”) is pleased to provide a portfolio update following the successful completion of its combination with Bear Creek Mining (see press release dated February 26, 2026). Daniel Earle, President and CEO of Highlander Silver, commented: “Highlander Silver is well positioned to fast-track project advancement across its portfolio of high-quality silver assets. This includes a focus on high-impact exploration, project optimization, and site preparation for development of Corani, the largest fully permitted primary silver project in the world, as well as permitting at San Luis, one of the highest M&I resource grade projects in both the gold and silver sectors. As of March 31, the Company had an unaudited...

Continue reading

Baker Hughes Secures Strategic Gas Technology Order Supporting Argentina’s Gas Infrastructure

Baker Hughes to supply three NovaLT™16 gas turbines with three centrifugal compressors and related services for a pipeline project to support Argentina’s LNG exports These gas compression units mark the first use of Baker Hughes’ NovaLT™ gas turbine technology in South America, reflecting growing demand for high-efficiency, lower-emissions turbomachineryHOUSTON and LONDON, April 07, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday it has secured a strategic order from San Matias Pipeline S.A. to supply three gas compression units for a major natural gas pipeline project in Argentina. The order consists of three NovaLT™16 gas turbines equipped with three centrifugal compressors, along with commissioning services, spare parts, special tools, and remote monitoring...

Continue reading

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences   Data highlights mechanism of action, outcomes in VLUs and DFUs, and comparative advantages over SANTYL® Findings support ongoing VALUE Phase III study and planned expansion into DFUs and pressure ulcers YAVNE, Israel, April 7, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced multiple oral and poster presentations at three leading wound care conferences: the Wound Healing Society (WHS) and the Symposium on Advanced Wound Care (SAWC) Spring 2026, taking place April 8–12 in Charlotte, North Carolina, and the European Wound Management Association (EWMA) 2026, taking place May 6–8 in Bremen, Germany. The presentations will showcase new preclinical and clinical data supporting...

Continue reading

Plug Participating in RBC Non-Deal Roadshow in Canada

SLINGERLANDS, N.Y., April 07, 2026 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive solutions for the hydrogen economy, will participate in a non-deal roadshow hosted by RBC. The meetings will provide an opportunity for institutional investors to engage with management on Plug’s business strategy, operational execution, and path to profitability. WHEN:Tuesday, April 7, 2026 – Toronto, CanadaWednesday, April 8, 2026 – Montreal, Canada WHO:Paul Middleton, CFO, Plug Power Roberto Friedlander, Vice President of Investor Relations, Plug PowerFurther detail on Plug’s investor conference and roadshow participation is available in the investor relations section of the Company’s website: https://www.ir.plugpower.com/events-and-presentations/default.aspx. About Plug Power Plug is building the global...

Continue reading

Schouw & Co. share buy-back programme, week 14 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 27 March 2026 101,283 668.66 67,723,666    Monday, 30 March 2026 1,000 649.15 649,147    Tuesday, 31 March 2026 1,000 659.00 659,000    Wednesday, 1 April 2026 1,000 668.00 668,000    Thursday, 2 April 2026 – – –    Friday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.